Viewing Study NCT06144970



Ignite Creation Date: 2024-05-06 @ 7:48 PM
Last Modification Date: 2024-10-26 @ 3:14 PM
Study NCT ID: NCT06144970
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-29
First Post: 2023-10-31

Brief Title: Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease
Sponsor: Kolon TissueGene Inc
Organization: Kolon TissueGene Inc

Study Overview

Official Title: A Phase I Double-blind Randomized Sham-controlled Dose-response Study Evaluating the Safety and Tolerability of TG-C in Subjects With Chronic Discogenic Lumbar Back Pain Due to Degenerative Disc Disease at 6 and 12 Months
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this study is to evaluate the safety and tolerability of TG-C in subjects with chronic discogenic lumbar back pain due to degenerative disc disease Participants will be administered a single intradiscal injection or subcutaneous injection for sham and followed up with in-clinic visits and telephone calls for 24 months
Detailed Description: A Phase I Double-blind Randomized Sham-controlled Dose-response Study Evaluating the Safety and Tolerability of TG-C in Subjects with Chronic Discogenic Lumbar Back Pain due to Degenerative Disc Disease at 6 and 12 Months male or female subjects with chronic discogenic lumbar back pain due to degenerative disc disease at one level TG-C is to be administered by a single intradiscal injection to the damaged disc via fluoroscopic guidance Sham will be a normal saline subcutaneous injection Subjects will be followed for 24 months with in-clinic visits and telephone calls after study drug administration

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None